Effect of leukocyte therapy on tumor necrosis factor-alpha and interferon-gamma production in patients with recurrent spontaneous abortion

American Journal of Reproductive Immunology

Volumn 59, Issue 3, 2008, Pages 242-250

  Gharesi Fard, Behrouz ^a   Zolghadri, Jaleh ^a   Kamali Sarvestani, Eskandar ^a,b  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

IFN c, leukocyte therapy; Recurrent spontaneous abortion; TNF a

Indexed keywords

CYTOKINE; GAMMA INTERFERON; TUMOR NECROSIS FACTOR ALPHA;

ADULT; ARTICLE; CLINICAL ARTICLE; COCULTURE; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; CYTOKINE PRODUCTION; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FOLLOW UP; HUMAN; HUMAN CELL; IMMUNOTHERAPY; IRAN; LEUKOCYTE; MONONUCLEAR CELL; PREDICTION; PREGNANCY OUTCOME; PRIORITY JOURNAL; PROGNOSIS; RECURRENT ABORTION; SPONTANEOUS ABORTION; SUPERNATANT;

ABORTION, HABITUAL; ADULT; FEMALE; FOLLOW-UP STUDIES; HUMANS; IMMUNOTHERAPY, ADOPTIVE; INTERFERON-GAMMA; ISOANTIGENS; LYMPHOCYTE ACTIVATION; PREGNANCY; T-LYMPHOCYTE SUBSETS; TH1 CELLS; TH2 CELLS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 39149123518     PISSN: 10467408     EISSN: 16000897     Source Type: Journal    
DOI: 10.1111/j.1600-0897.2007.00569.x     Document Type: Article

References (41)

1. Regan L, Rai R: Epidemiology and the medical cause of miscarriage. Bailliere's Clin Obstet Gynaecol 2000; 14:839-854.
2. Li TC, Makris M, Tomsu M, Tuckerman EM, Laird SM: Recurrent miscarriage, aetiology, management and prognosis. Hum Reprod Update 2002; 8:463-481.
3. Stephenson MD: Frequency of factors associated with habitual abortion in 197 couples. Fertil Steril 1996; 66:24-29.
4. Mowbray JF, Gibbings CR, Liddel H, Unaderwood J, Reginald PW, Beard RW: Immunization with paternal cells. Lancet 1985; 1:941-943.
5. Ober C, Karrison T, Odem RR, Barnes RB, Branch DW, Stephenson MD, Baron B, Walker MA, Scott JR, Schreiber JR: Mononuclear-cell immunisation in prevention of recurrent miscarriages: A randomised trial. Lancet 1999; 354:365-369.
6. Porter TF, LaCoursiere Y, Scott JR: Immunotherapy for recurrent miscarriage. Cochrane Database Syst Rev 2006; CD000112.
7. Christiansen OB, Nielsen SH, Pedersen B: Active or passive immunization in unexplained recurrent miscarriage. J Reprod Immunol 2004; 62:41-52.
8. Pandey MK, Thakur S, Agrawal S: An update in recurrent spontaneous abortion. Arch Gynecol Obstet 2005; 272:95-108.
9. Ramhorst R, Agriello E, Zittermann S, Pando M, Larriba J, Irigoyen M, Cortelezzi M, Auge L, Lombardi E, Etchepareborda JJ, Contreras Ortiz C, Fainboim L: Is the paternal mononuclear cells' immunization a successful treatment for recurrent spontaneous abortion?. Am J Reprod Immunol 2000; 44:129-135.
10. Tamura M, Takakuwa K, Arakawa M, Yasuda M, Kazama Y, Tanaka K: Relationship between MLR blocking antibodies and the outcome of the third pregnancy in patients with two consecutive spontaneous abortions. J Perinat Med 1998; 26:49-53.
11. Prigoshin N, Tambutti ML, Redal MA, Gorgorza S, Lancuba SM, Nicholson R, Testa R: Microchimerism and blocking activity in women with recurrent spontaneous abortion (RSA) after alloimmunization with the partner's lymphocytes. J Reprod Immunol 1999; 44:41-54.
12. Chaouat G, Ledee-Bataille N, Dubanchet S, Zourbas S, Sandra O, Martal J: Reproductive immunology 2003: Reassessing the Th1/Th2 paradigm?. Immunol Lett 2004; 92:207-214.
13. Zenclussen AC, Gelof K, Zenclussen ML, Ritter T, Kotsch K, Leber J, Volk HD: Abnormal T-cell reactivity against paternal antigens in spontaneous abortion: Adoptive transfer of pregnancy-induced CD4+ CD25+ T regulatory cells prevents fetal rejection in a murine abortion model. Am J Pathol 2005;166: 811-822.
14. Wegmann TG, Lin H, Guilbert L, Mosmann TR: Bidirectional cytokine interactions in the maternal-fetal relationship: Is successful pregnancy a TH2 phenomenon?. Immunol Today 1993; 14:353-356.
15. Chaouat G, Meliani AA, Martal J, Raghupathy R, Elliot JJ, Mosmann TR, Wegmann TG: IL-10 prevents naturally occurring fetal loss in the CBAxDBA/ 2 mating combination and local defect in IL-10 production in this abortion-prone combination is corrected by in vivo injection of IFN-γ. J Immunol 1995; 154:4261-4268.
16. Yui J, Garcia-Lloret M, Wegmann TG, Guilbert L: Cytotoxicity of tumor necrosis factor-alpha and gamma-interferon against primary human placental trophoblasts. Placenta 1994;15: 819-835.
17. Haimovici F, Hill JA, Anderson DJ: The effects of stable products of activated lymphocytes and macrophages on blastocyte implantation events in vitro. Biol Reprod 1991; 44:69-75.
18. Marzi M, Vigano A, Trabattoni D, Villa ML, Salvaggio A, Clerici E, Clerici M: Characterization of type 1 and type 2 cytokine production profile in physiologic and pathologic human pregnancy. Clin Exp Immunol 1996; 106:127-133.
19. Guilbert L: There is a bias against type 1 (inflammatory) cytokine expression and function in pregnancy. J Reprod Immunol 1996; 32:105-110.
20. Raghupathy R: Th1-type immunity is incompatible with successful pregnancy. Immunol Today 1997; 18:478-482.
21. Raghupathy R, Makhseed M, Azizieh F, Hassan N, Al-Azemi M, Al-shamali E: Maternal Th1 and Th2 type reactivity to placental antigens in normal human pregnancy and unexplained recurrent spontaneous abortions. Cell Immunol 1999; 196:122-130.
22. Makhseed M, Raghupathy R, Azizieh F, Al-Azemi M, Hassan N, Bandar A: Mitogen-induced cytokine responses of maternal peripheral blood lymphocytes indicate a differential Th-type bias in normal pregnancy and pregnancy failure. Am J Reprod Immunol 1999; 42:273-281.
23. Yokoo T, Takakuwa K, Ooki I, Kikuchi A, Tamura M, Tanaka K: Alteration of TH1 and TH2 cells by intracellular cytokine detection in patients with unexplained recurrent abortion before and after immunotherapy with the husband's mononuclear cells. Fertil Steril 2006; 85:1452-1458.
24. Hill JA: T-helper 1-type immunity tE trophoblast: evidence for a new immunological mechanism for recurrent abortion in women. Hum Reprod 1995; 2:114-120.
25. Daher S, Fonseca F, Ribeiro OG, Musatti CC, Gerbase-DeLima M: Tumor necrosis factor during pregnancy and at the onset of labor and spontaneous abortion. Eur J Obstet Gynecol Reprod Biol 1999; 83:77-79.
26. Hadinedoushan H, Mahroo M, Abbas A, Firouzeh A, Nadia H: Cytokine production by peripheral blood mononuclear cells in recurrent miscarriage. Cytokine 2004; 28:83-86.
27. Jenkins C, Roberts J, Wilson R, MacLean MA, Shilito J, Walker JJ: Evidence of a TH1 type response associated with recurrent miscarriage. Fertil Steril 2000; 73:1206-1208.
28. Reinhard G, Noll A, Schlebusch H, Mallmann P, Ruecker AV: Shifts in the TH1/TH2 balance during human pregnancy correlate with apoptotic changes. Biochem Biophys Res Commun 1998; 245:933-938.
29. Bates MD, Quenby S, Takakuwa K, Johnson PM, Vince GS: Aberrant cytokine production by peripheral blood mononuclear cells in recurrent pregnancy loss?. Hum Reprod 2002; 17:2439-2444.
30. Shimada S, Iwabuchi K, Kato EH, Morikawa M, Sakuragi N, Onoe K, Minakami H, Yamada H: No difference in natural-killer-T cell population, but Th2/ Tc2 predominance in peripheral blood of recurrent aborters. Am J Reprod Immunol 2003; 50:334-339.
31. Ashkar AA, Di Santo JP, Croy BA: IFN-γ contributes to initiation of uterine vascular modification, decidual integrity, and uterine natural killer cell maturation during normal murine pregnancy. J Exp Med 2000; 192:259-269.
32. Ashkar AA, Croy BA: Functions of uterine natural killer cells are mediated by interferon gamma production during murine pregnancy. Semin Immunol 2001; 13:235-241.
33. Zenclussen AC: Regulatory T cells in pregnancy. Springer Semin Immunopathol 2006; 28:31-39.
34. Hunt JS, Chen HL, Piller L: Tumor necrosis factors: pivotal components of pregnancy?. Biol Reprod 1996; 54:554-562.
35. Tranchot-Diallo J, Gras G, Parnet-Mathieu F, Benveniste O, Marce D, Roques P, Milliez J, Chaouat G, Dormont D: Modulations of cytokine expression in pregnant women. Am J Reprod Immunol 1997; 37:215-226.
36. Chernyshov VP, Vodyanik MA, Pisareva SP: Lack of soluble TNF-receptors in women with recurrent spontaneous abortion and possibility for its correction. Am J Reprod Immunol 2005; 54:284-291.
37. Mueller-Eckhardt G, Mallmann P, Neppert J, Lattermann A, Melk A, Heine O, Pfeiffer R, Zingsem J, Domke N, Mohr-Pennert A: Immunogenetic and serological investigations in nonpregnant and in pregnant women with a history of recurrent spontaneous abortions. German RSA/IVIG Study Group. J Reprod Immunol 1994; 27:95-109.
38. Kruse C, Varming K, Christiansen OB: Prospective, serial investigations of in-vitro lymphocyte cytokine production, CD62L expression and proliferative response to microbial antigens in women with recurrent miscarriage. Hum Reprod 2003; 18:2465-2472.
39. Hayakawa S, Karasaki-Suzuki M, Itoh T, Ishii M, Kanaeda T, Nagai N, Takahashi-Yamamoto N, Tochigi M, Chishima F, Fujii TK, Oyama J, Kitanaka S, Satoh K: Effects of paternal lymphocyte immunization on peripheral Th1/Th2 balance and TCR V beta and V gamma repertoire usage of patients with recurrent spontaneous abortions. Am J Reprod Immunol 2000; 43:107-115.
40. Szpakowski A, Malinowski A, Glowacka E, Wilczynski JR, Kolasa D, Dynski M, Tchorzewski H, Zeman K, Szpakowski M: The influence of paternal lymphocyte immunization on the balance of Th1/Th2 type reactivity in women with unexplained recurrent spontaneous abortion. Ginekol Pol 2000; 71:586-592.
41. Szpakowski A, Malinowski A, Cieslak J, Nowak M, Wilczynski JR, Banasik M, Szpakowski M, Tchorzewski H: Influence of paternal lymphocyte immunization on the selected subpopulations of peripheral blood lymphocytes in women with recurrent spontaneous abortions of unknown etiology. Ginekol Pol 2003; 74:288-296.